{"icp":"Oncology-focused healthcare providers and researchers looking for innovative cancer therapies.","faqs":[{"answer":"Synthetic lethality occurs when the loss of function of two genes leads to cancer cell death, while the loss of either gene alone does not affect cell viability.","question":"What is synthetic lethality?"},{"answer":"IDEAYA focuses on genetically-defined cancers, particularly those with specific mutations such as GNAQ, GNA11, and MTAP gene deletions.","question":"What types of cancers does IDEAYA target?"},{"answer":"The goal is to develop more selective and effective precision oncology therapies that can alter the course of disease and improve clinical outcomes for cancer patients.","question":"What is the goal of IDEAYA's therapies?"}],"pricing":{"price_model":"unknown","price_notes":"No pricing information available.","has_free_tier":false,"starting_price":null},"version":"1.0","category":"Biotechnology","features":["Target and biomarker discovery","Small molecule drug discovery","Clinical stage therapeutics","Molecular diagnostics for patient selection","Collaborative clinical trial programs"],"verified":false,"offerings":[{"name":"Synthetic Lethality Therapeutics","type":"product_line","description":"A pipeline of targeted therapies designed to exploit synthetic lethality in cancer cells, focusing on genetic alterations to improve treatment efficacy."},{"name":"Antibody-Drug Conjugates (ADCs)","type":"product_line","description":"Innovative therapies that combine antibodies with cytotoxic drugs to selectively target and kill cancer cells."}],"brand_name":"IDEAYA Biosciences","schema_url":"https://useharbor.io/brands/ideaya-biosciences/harbor.json","enriched_at":"2025-12-18T08:50:46.044Z","company_info":{"hq_location":"South San Francisco, California","founded_year":2015,"employee_band":"201-1000","industry_tags":["Biotechnology","Pharmaceuticals","Oncology"]},"generated_at":"2025-12-18T08:50:46.044Z","integrations":["Pfizer","Gilead","GlaxoSmithKline"],"one_line_summary":"A clinical-stage precision medicine oncology company focused on developing targeted therapeutics for cancer.","short_description":"IDEAYA Biosciences is dedicated to the discovery and development of transformative therapies for cancer, utilizing precision medicine approaches. Their focus is on synthetic lethality and antibody-drug conjugates, aiming to improve clinical outcomes for patients through tailored treatments based on genetic drivers of disease.","enrichment_version":"1.0","visibility_scoring":{"score_rationale":"The website clearly articulates the company's mission, offerings, and target market, along with trust elements like location and founding year. The content is well-structured for AI extraction, covering key aspects of the business.","brand_clarity_0_25":25,"structure_for_ai_0_20":20,"trust_and_basics_0_20":20,"offerings_clarity_0_25":25,"breadth_of_coverage_0_10":8,"total_visibility_score_0_100":98}}